2024-05-16 |
[Comment] Targeting B cells in neuromyelitis optica spectrum disorder |
Chao Zhang, Fu-Dong Shi |
|
2024-05-16 |
[Comment] Stopping haematoma growth: the search for the right time, place, and agent |
Sabine Voigt, Marieke J H Wermer |
|
2024-05-16 |
[Personal View] Climate change and disorders of the nervous system |
Sanjay M Sisodiya, Medine I Gulcebi, Francesco Fortunato, James D Mills, Ethan Haynes, Elvira Bramon, Paul Chadwick, Olga Ciccarelli, Anthony S David, Kris De Meyer, Nick C Fox, Joanna Davan Wetton, Martin Koltzenburg, Dimitri M Kullmann, Manju A Kurian, |
|
2024-05-16 |
[Editorial] Forging ahead in haemorrhagic stroke research |
The Lancet Neurology |
|
2024-05-16 |
[In Context] SARS-CoV-2 infection as a cause of neurodegeneration |
Daniel Bonhenry, Mirren Charnley, Jorge Gonçalves, Per Hammarström, Michael T Heneka, Ruth Itzhaki, Jean-Charles Lambert, Misbah Mannan, Abdul Mannan Baig, Jinte Middeldorp, Sofie Nyström, Nicholas P Reynolds, Maria Stefanatou, Joshua T Berryman |
|
2024-05-16 |
[In Context] The torment of needing to know for sure |
Andrew J Lees |
|
2024-05-16 |
[Comment] Neurology and climate change |
Larry Junck, Ali Saad, Bret Andrews |
|
2024-05-16 |
[In Context] Thien Phu Do |
|
|
2024-05-16 |
[Rapid Review] B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases |
Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos |
|
2024-05-16 |
[In Context] Pooja Khatri: driven by appreciation and gratitude |
Priya Venkatesan |
|
2024-05-16 |
[Correspondence] Negative findings from trials with NLY01 or deferiprone for Parkinson's disease – Author's reply |
Andrew McGarry |
|
2024-05-16 |
[Corrections] Correction to Lancet Neurol 2024; 23: 465–76 |
|
|
2024-05-16 |
[Correspondence] The prescription of valproate: risk of harm |
Fergus Rugg-Gunn, David Hunt |
|
2024-05-16 |
[Correspondence] Negative findings from trials with NLY01 or deferiprone for Parkinson's disease |
Thomas Müller, Jan Dominique Möhr |
|
2024-05-16 |
[Correspondence] The prescription of valproate: risk of harm |
Alison Cave |
|
2024-05-16 |
[Comment] Speculation on the transmissibility of Alzheimer's disease |
Alifiya Kapasi, Julie A Schneider |
|
2024-05-16 |
[Comment] Elucidating a new path of CSF transport in the CNS |
Helene Benveniste, Jean-Leon Thomas |
|
2024-05-16 |
[Review] Haemorrhagic stroke and brain vascular malformations in women: risk factors and clinical features |
Mariam Ali, Ellis S van Etten, Saloua Akoudad, Joanna D Schaafsma, Marieke C Visser, Mahsoem Ali, Charlotte Cordonnier, Else Charlotte Sandset, Catharina J M Klijn, Ynte M Ruigrok, Marieke J H Wermer |
|
2024-05-16 |
[Comment] Cerebral cavernous malformations: to operate or not? |
Gabriël J E Rinkel |
|
2024-05-16 |
[Articles] Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial |
Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R Cutter, Romain Marignier, Ari J Green, Orhan Aktas, Hans-Peter Hartung, Dewei She, William Rees, Michael Smith, Daniel Cimbora, Eli |
|
2024-05-16 |
[In Context] The Egyptian origins of neuroanatomy |
Emmanuel Drouin, Arnaud Kwiatkowski, Patrick Hautecoeur |
|
2024-05-16 |
[Articles] Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial |
Nawaf Yassi, Henry Zhao, Leonid Churilov, Teddy Y Wu, Henry Ma, Huy-Thang Nguyen, Andrew Cheung, Atte Meretoja, Duy Ton Mai, Timothy Kleinig, Jiann-Shing Jeng, Philip M C Choi, Phuc Dang Duc, Helen Brown, Annemarei Ranta, Neil Spratt, Geoffrey C Cloud, Ha |
|
2024-05-16 |
[Corrections] Correction to Lancet Neurol 2024; 23: 393–403 |
|
|
2024-05-16 |
[Articles] Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial |
CARE pilot trial collaboration |
|
2024-05-16 |
[Articles] RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses |
Emil K Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D Fox, Silke Appel-Cresswell, A Jon Stoessl, Alex Rajput, Ali H Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B Haack, Suzan |
|
2024-05-16 |
[Comment] New gene involved in the pathogenesis of Parkinson's disease |
Mathias Toft |
|
2024-04-16 |
[Correspondence] The need for partnerships in migration for medical workers |
Caroline Theoharides |
|
2024-04-16 |
[Correspondence] The African Stroke Organization Conference 2023 |
Fred Stephen Sarfo, Mehari Gebreyohanns, Rufus Akinyemi, Ad Adams Ebenezer, Bruce Ovbiagele, Mayowa Owolabi, ASOC 2023 Planning Committee |
|
2024-04-16 |
[Comment] Surrogate endpoints for progressive multifocal leukoencephalopathy |
Joep Killestein, Mike P Wattjes |
|
2024-04-16 |
[Comment] Factors affecting brain maturation trajectories in early childhood |
Thiviya Selvanathan, Steven P Miller |
|
2024-04-16 |
[Comment] Insights into the progression of genetic Alzheimer's disease from tau PET |
Agneta Nordberg |
|
2024-04-16 |
[Comment] Association of Pick's disease with the MAPT H2 haplotype |
Gaël Nicolas |
|
2024-04-16 |
[Comment] A disease-specific therapy in facioscapulohumeral muscular dystrophy |
Nicol Voermans, John Vissing |
|
2024-04-16 |
[Correspondence] Dementia prevention: from idealism to realism |
Abolfazl Avan, Vladimir Hachinski |
|
2024-04-16 |
[In Context] Felicia Bliss Axelrod: the dysautonomia pioneer |
Maria Trinidad Herrero |
|
2024-04-16 |
[Personal View] Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials |
Irene Cortese, Gina Norato, Patrick R Harrington, Therri Usher, Ilaria Mainardi, Guillaume Martin-Blondel, Paola Cinque, Eugene O Major, Virginia Sheikh |
|
2024-04-16 |
[Review] Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatment |
Michael C Ferraro, Neil E O’Connell, Claudia Sommer, Andreas Goebel, Janet H Bultitude, Aidan G Cashin, G Lorimer Moseley, James H McAuley |
|
2024-04-16 |
[Editorial] Important lessons on healthcare from rare diseases |
The Lancet Neurology |
|
2024-04-16 |
[Articles] Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study |
Julie K Wisch, Nicole S McKay, Anna H Boerwinkle, James Kennedy, Shaney Flores, Benjamin L Handen, Bradley T Christian, Elizabeth Head, Mark Mapstone, Michael S Rafii, Sid E O’Bryant, Julie C Price, Charles M Laymon, Sharon J Krinsky-McHale, Florence Lai, |
|
2024-04-16 |
[Review] Improving epilepsy diagnosis across the lifespan: approaches and innovations |
Jacob Pellinen, Emma C Foster, Jo M Wilmshurst, Sameer M Zuberi, Jacqueline French |
|
2024-04-16 |
[Articles] Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial |
Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland, Leo H Wang, Angela Genge, Sabrina Sacconi, Hanns Lochmüller, David Reyes-Leiva, Jordi Diaz-Manera, Jorge Alonso-Perez, Nuria Muelas, Juan J Vilchez, Alan Pestronk, Summer Gi |
|
2024-04-16 |
[Articles] MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study |
Rebecca R Valentino, William J Scotton, Shanu F Roemer, Tammaryn Lashley, Michael G Heckman, Maryam Shoai, Alejandro Martinez-Carrasco, Nicole Tamvaka, Ronald L Walton, Matthew C Baker, Hannah L Macpherson, Raquel Real, Alexandra I Soto-Beasley, Kin Mok, |
|
2024-04-16 |
[In Context] A neurotransmitter with a fascinating story |
Jennifer Pocock |
|
2024-04-16 |
[In Context] What we remember |
Marco De Ambrogi |
|
2024-04-16 |
[In Context] Fostering diversity, equity, and inclusion in Europe |
Marianne de Visser, Elena Moro |
|
2024-04-16 |
[In Context] Violiza Inoa |
|
|
2024-04-16 |
[Corrections] Correction to Lancet Neurol 2024; 23: 344–81 |
|
|
2024-04-16 |
[Articles] Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial |
Alberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, Alberto Albanese, Aaron Ellenbogen, Joaquim J Ferreira, Nir Giladi, Tanya Gurevich, Sharon Hassin-Baer, Jorge Hernandez-Vara, Stuart H Isaacson, Karl Kieburtz, Peter A LeWitt, Lydia Lopez-Manzanares, C Warr |
|
2024-04-16 |
[Comment] Fluctuations in Parkinson's disease: progress and challenges |
Francisco Cardoso, Eduardo Tolosa |
|